Orange Book product · Generic (ANDA)
RAMIPRIL
RAMIPRIL
At a glance
Jun 08, 2011
Approved
Generic (ANDA)
Application
AB
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Jun 08, 2011
15 yr 3 mo ago
Today
Pharmaceutical detail
Active ingredient
RAMIPRIL
Strength
1.25MG
Dosage form
CAPSULE
Route
ORAL
TE code
AB
Application
ANDA 091604
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of RAMIPRIL
- 2025VOSTALLYBrand (NDA)
NDA 219757 · ROSEMONT PHARMS
- 2007ALTACEBrand (NDA)
NDA 022021 · KING PFIZER
- 1991ALTACEBrand (NDA)
NDA 019901 · KING PHARMS LLC
- 2015RAMIPRILGeneric (ANDA)
ANDA 091069 · APOTEX
- 2014RAMIPRILGeneric (ANDA)
ANDA 202392 · ACCORD HLTHCARE
- 2011RAMIPRILGeneric (ANDA)
ANDA 090650 · NATCO PHARMA
- 2009RAMIPRILGeneric (ANDA)
ANDA 090697 · ZYDUS PHARMS USA INC
- 2009RAMIPRILGeneric (ANDA)
ANDA 078849 · RANBAXY LABS LTD
- 2008RAMIPRILGeneric (ANDA)
ANDA 078832 · ZYDUS PHARMS USA
- 2008RAMIPRILGeneric (ANDA)
ANDA 077004 · CIPLA
- 2008RAMIPRILGeneric (ANDA)
ANDA 079116 · COREPHARMA
- 2008RAMIPRILGeneric (ANDA)
ANDA 077513 · ACTAVIS ELIZABETH
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
